Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News and Views
Nature Immunology 6, 646–648 (1 July 2005) | doi:10.1038/ni0705-646
Type I interferon and cancer immunoediting
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
